Efficacy, Safety and Future Perspectives of JAK Inhibitors in the IBD Treatment
Review
[키워드] Affect
approved
biologic
clinical development
Compliance
Crohn’s disease
cytokine
Effectiveness
Efficacy
Future
IBD
immune pathways
immunothrombosis
implicated
IMPROVE
Inflammatory bowel disease
inhibiting
inhibitors
Jak
JAK inhibitor
jak inhibitors
Janus kinase
medical need
monoclonal antibodies
pandemic
Pathogenesis
patients
patients with COVID-19
question
risk
Safety
safety profile
several limitations
Signaling
small molecule
Small molecules
susceptibility
the SARS-CoV-2
therapeutic response
therapy
Thromboembolic events
thrombotic complication
Treatment
treatment strategy
ulcerative colitis
[DOI] 10.3390/jcm10235660 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/jcm10235660 PMC 바로가기 [Article Type] Review